These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21432601)

  • 1. Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.
    Rastmanesh R
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):149-57. PubMed ID: 21432601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA; Faraone SV
    Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining.
    Gonon F
    Trends Neurosci; 2009 Jan; 32(1):2-8. PubMed ID: 18986716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF
    J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder (ADHD): improved understanding and novel drug treatment.
    Marsden CA
    Neuropharmacology; 2009 Dec; 57(7-8):577-8. PubMed ID: 19733580
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    van der Kooij MA; Glennon JC
    Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
    Ludolph AG; Kassubek J; Schmeck K; Glaser C; Wunderlich A; Buck AK; Reske SN; Fegert JM; Mottaghy FM
    Neuroimage; 2008 Jul; 41(3):718-27. PubMed ID: 18424180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.
    Swanson JM; Kinsbourne M; Nigg J; Lanphear B; Stefanatos GA; Volkow N; Taylor E; Casey BJ; Castellanos FX; Wadhwa PD
    Neuropsychol Rev; 2007 Mar; 17(1):39-59. PubMed ID: 17318414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications.
    Levy F
    Aust N Z J Psychiatry; 2007 Jan; 41(1):10-6. PubMed ID: 17464676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Fowler JS; Ding YS
    Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.
    Stahl SM
    J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003
    [No Abstract]   [Full Text] [Related]  

  • 17. Attention deficit and hyperactivity disorder: review of genetic association studies.
    Galili-Weisstub E; Segman RH
    Isr J Psychiatry Relat Sci; 2003; 40(1):57-66. PubMed ID: 12817670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropsychopharmacology of attention-deficit/hyperactivity disorder.
    Pliszka SR
    Biol Psychiatry; 2005 Jun; 57(11):1385-90. PubMed ID: 15950012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study supports medication for ADHD.
    Health News; 2000 Feb; 6(2):5. PubMed ID: 10734823
    [No Abstract]   [Full Text] [Related]  

  • 20. The neurological basis of attention deficit hyperactivity disorder.
    Ballard S; Bolan M; Burton M; Snyder S; Pasterczyk-Seabolt C; Martin D
    Adolescence; 1997; 32(128):855-62. PubMed ID: 9426808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.